ACTREC Cancer Immunology JRF Walk IN

TATA MEMORIAL CENTRE 
ADVANCED CENTRE FOR TREATMENT, RESEARCH ANDEDUCATION IN CANCER 
Kharghar, 
Navi Mumbai- 410 210 

No. ACTREC/ADVT-159/2025 21.08.2025 
INTERVIEW FOR JUNIOR RESEARCH FELLOW (ON PROJECT) 

Project Title:-“Cross-talk between gamma-delta T cells and tumor associated macrophages in governing immunosuppression in ovarian cancer.” 

ESSENTIAL EDUCATIONAL QUALIFICATION: *M.Sc. in Life Sciences with minimum 60% marks in the qualifying exam with CSIR-UGC NET and GATE qualification. 

Experience: Proven experience (minimum SIX months) working with mouse models of cancer is mandatorily required. 

Desirable: Candidates with previous experience in flow cytometry and immunofluorescence will be given preference. 

*M.Sc. degree having duration of one year course will not be considered. Selected candidate will have to join at the earliest; hence result-awaited candidates will not be eligible to apply for the post. 

CONSOLIDATED SALARY: Consolidated Indian Rupees 38,440/- per month 

DURATION: Six months and extendable. The work progress of candidates will be monitored and extension may be given after 6 months. 

Eligible candidates may apply and send their CV, educational documents and Aadhaar card soft copy in a pdf format to recruitment.biswaslab@gmail.com Application should contain the subject “Application for the post of Junior Research Fellow”. Name & Address Email ID Mob. No. Educational Qualification M.Sc. Percentage National Exam (NET/GATE with validity etc…) 

Experience: (How many Months) (From : To)(Minimum 6 Months) 

The last date of application is 4 th September 2025 till 2.00 PM. 

The Interview will be scheduled on 9th September, 2025. Only the short-listed candidates will be contacted by e-mail and notified about the interview timings.

More Info: https://actrec.gov.in/sites/default/files/2025-08/Final%20Advt-159-Junior%20Research%20%20Fellow%20.pdf

Subscribe our X Channel  to get Latest and more updates: Join Now!

To Get All Updates from helpBIOTECH, Subscribe Now by Email

Post a Comment

0 Comments